Wallace Advisory Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$342K Buy
4,765
+539
+13% +$41.5K 0.37% 64
2025
Q4
$335K Sell
4,226
-3,257
-44% -$257K 0.35% 78
2025
Q3
$516K Sell
7,483
-2,350
-24% -$161K 0.41% 70
2025
Q2
$666K Buy
9,833
+988
+11% +$64.8K 0.48% 52
2025
Q1
$397K Buy
8,845
+1,236
+16% +$74K 0.27% 107
2024
Q4
$478K Buy
7,609
+132
+2% +$7.41K 0.33% 85
2024
Q3
$442K Sell
7,477
-264
-3% -$15.4K 0.32% 83
2024
Q2
$457K Buy
+7,741
New +$484K 0.33% 81

Other funds holding CVS

Wallace Advisory Group's CVS Position: Q1 2026 in Review

Wallace Advisory Group increased its CVS Health (CVS) stake by 13% in Q1 2026, buying an estimated $41.5K and bringing the position to 4,765 shares worth $342K. The position accounts for 0.37% of the portfolio, ranked #64.

Wallace Advisory Group first reported a position in CVS in Q2 2024 and has held it in 8 quarters since. The position peaked at $666K in Q2 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Wallace Advisory Group held 4,765 shares of CVS Health worth $342K as of Q1 2026.
  • Wallace Advisory Group bought 539 CVS Health shares in Q1 2026, an estimated $41.5K.
  • CVS Health made up 0.37% of Wallace Advisory Group's portfolio in Q1 2026, its #64 holding.
  • Wallace Advisory Group first reported a position in CVS Health in Q2 2024 and has held it in 8 quarters since.
  • Wallace Advisory Group's CVS Health position peaked at $666K in Q2 2025.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Wallace Advisory Group's 13F filing for Q1 2026, filed 21 Apr 2026.